Mirca Lazzaretti
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Bone health and treatments
- Peptidase Inhibition and Analysis
- Chemokine receptors and signaling
Papers in
-
- Bone Metabolism and Diseases 6
- Ubiquitin and proteasome pathways 6
- Hematology 21
- Multiple Myeloma Research and Treatments 20
- Co-authors
- Nicola Giuliani (23 shared papers)Sabrina Bonomini (16 shared papers)Vittorio Rizzoli (16 shared papers)Cristina Mancini (9 shared papers)Régis Bataille (3 shared papers)Sophie Barillé‐Nion (2 shared papers)Simona Colla (14 shared papers)Francesca Morandi (7 shared papers)
- Journals
- Blood (13 papers)Leukemia (5 papers)Cancer Research (2 papers)Pharmacology (1 paper)Veterinary Research Communications (1 paper)
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Mirca Lazzaretti
43 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 112
- Hematology 974
- Oncology 1.2k
- Molecular Biology 1.0k
- Cancer Research 205
- Orthopedics and Sports Medicine 111
Countries citing papers authored by Mirca Lazzaretti
This map shows the geographic impact of Mirca Lazzaretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirca Lazzaretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirca Lazzaretti more than expected).
Fields of papers citing papers by Mirca Lazzaretti
This network shows the impact of papers produced by Mirca Lazzaretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirca Lazzaretti. The network helps show where Mirca Lazzaretti may publish in the future.
Co-authors
The 25 scholars most cited alongside Mirca Lazzaretti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 302 | |
| 2 | 2005 | 248 | |
| 3 | 2002 | 201 | |
| 4 | 2007 | 191 | |
| 5 | 2019 | 108 | |
| 6 | 2012 | 100 | |
| 7 | 2003 | 92 | |
| 8 | 2013 | 89 | |
| 9 | 2007 | 81 | |
| 10 | CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. | 2006 | 65 |
| 11 | 2001 | 64 | |
| 12 | 2005 | 59 | |
| 13 | 2008 | 54 | |
| 14 | 2009 | 49 | |
| 15 | 2008 | 42 | |
| 16 | 2012 | 42 | |
| 17 | 2010 | 38 | |
| 18 | 2018 | 37 | |
| 19 | 2005 | 34 | |
| 20 | 2004 | 30 |
About Mirca Lazzaretti
Mirca Lazzaretti is a scholar working on Molecular Biology, Hematology, Oncology, Surgery and Immunology and Allergy, having authored 43 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Bone health and treatments (9 papers), Bone Metabolism and Diseases (6 papers), Ubiquitin and proteasome pathways (6 papers), Cell Adhesion Molecules Research (5 papers), Peptidase Inhibition and Analysis (5 papers), Chemokine receptors and signaling (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Hematology (974 citations), Oncology (1.2k citations), Molecular Biology (1.0k citations), Cancer Research (205 citations) and Orthopedics and Sports Medicine (111 citations). Mirca Lazzaretti has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Nicola Giuliani, Sabrina Bonomini, Vittorio Rizzoli, Cristina Mancini, Régis Bataille, Sophie Barillé‐Nion, Simona Colla, Francesca Morandi, Roberto Sala and Sara Tagliaferri. Their work appears in journals such as Blood, Leukemia, Cancer Research, Pharmacology and Veterinary Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.